Mannucci E, Mangia PP, Pradelli L. Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes. Farmeconomia. Health Economics and Therapeutic Pathways. 2020;21(1S). https://doi.org/10.7175/fe.v21i1S.1490